Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dr Noemi Roy has received funding in the 2020-21 round of the Public Engagement with Research Seed Fund as one of seven projects for innovative work to engage the public with medical research.

© Shutterstock

FOCUS ON RACISM- MAKING A DIFFERENCE FOR SICKLE CELL DISEASE

Dr Noémi Roy (Radcliffe Department of Medicine) received funding to develop a project aimed to increase understanding, reduce stigma, and improve the quality of life of people living with sickle cell disease. People who live with Sickle cell disease (SCD) are almost exclusively of Black African and Afro-Caribbean origin. This genetically inherited condition puts people at risk of childhood strokes, severe painful attacks, kidney failure and early death. To address the difficult topic of racism in a safe and collaborative environment, we propose to carry out focus groups including members of the healthcare team, people living with sickle cell disease, members of the public of Black African and Afro-Caribbean ethnic origin, and an impartial professional moderator. These will explore attitudes and thoughts about whether and how racism exists in our service, how this impacts the health of the patients, their ability to access services and seek support and advice, how this harms the long term relationship between the health care team and the patients and the general public, and what interventions could be put in place to reduce this.

Read more about the rest of the projects on the Medical Sciences Division website

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

Biotech spinout MiroBio acquired by Gilead Sciences for ~£332m

Co-founded by Simon Davis, MiroBio focuses on developing therapeutics for inflammatory diseases.

Six RDM research groups secure LEAF Sustainability Awards

The Laboratory Efficiency Assessment Framework (LEAF) aims to support research groups to embed sustainability into their work.

Ewa Gogola receives Wellcome Early Career Award

Dr Ewa Gogola from the Patel Group in the MRC Molecular Haematology Unit has been awarded funding by the Wellcome Trust for the project ‘DNA damage-induced hepatocyte polyploidisation- how it happens and what are its consequences?’

Novel all-in-one vaccine developed to tackle future coronavirus threats

Up to $30 million in funding has been announced by the Coalition for Epidemic Preparedness Innovations (CEPI) to bring a new nanoparticle vaccine offering protection against a range of coronaviruses to clinical trial.

James Davies named as Lister Research Prize Fellow

James Davies has been named as one of eight researchers selected for the 2022 Fellowship scheme.

Understanding the interplay of dietary iron, anaemia and the immune system

Four related projects aim to unravel how the iron we eat shapes how the immune system develops and responds to vaccines.